ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
238.53
+4.42 (1.89%)
At close: Nov 11, 2026, 4:00 PM EST
238.81
+0.28 (0.12%)
Pre-market: Nov 12, 2026, 9:14 AM EST
ResMed Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 5,733 | 5,653 | 5,146 | 4,685 | 4,223 | 3,578 | |
Revenue Growth | 9.04% | 9.85% | 9.84% | 10.95% | 18.02% | 11.93% |
Cost of Revenue | 2,192 | 2,170 | 2,059 | 1,997 | 1,837 | 1,514 |
Gross Profit | 3,541 | 3,484 | 3,087 | 2,688 | 2,386 | 2,064 |
Selling, General & Admin | 1,121 | 1,108 | 991.02 | 917.14 | 874 | 737.51 |
Research & Development | 392.49 | 378.29 | 331.28 | 307.53 | 287.64 | 253.58 |
Amortization of Goodwill & Intangibles | 77.25 | 77.25 | 77.39 | 79.48 | 72.42 | 70.73 |
Operating Expenses | 1,591 | 1,564 | 1,400 | 1,304 | 1,234 | 1,062 |
Operating Income | 1,950 | 1,920 | 1,687 | 1,384 | 1,152 | 1,002 |
Interest Expense | - | - | -0.59 | -49.72 | -51.13 | -22.31 |
Interest & Investment Income | 52.3 | 44.71 | - | - | - | - |
Earnings From Equity Investments | 7.35 | 6.96 | 3.64 | -1.85 | -7.27 | -8.49 |
Currency Exchange Gain (Loss) | -7.3 | -8.61 | -2.39 | -0.14 | -0.45 | 2.81 |
Other Non Operating Income (Expenses) | 7.58 | 4.66 | 1.83 | 0.66 | -1.51 | 0.39 |
EBT Excluding Unusual Items | 2,010 | 1,968 | 1,690 | 1,333 | 1,092 | 974.55 |
Merger & Restructuring Charges | -57.08 | -33.23 | -2.03 | -64.23 | -20.13 | -1.86 |
Gain (Loss) on Sale of Investments | -3.11 | -15.01 | -10.3 | -4.05 | 9.92 | -12.2 |
Pretax Income | 2,012 | 1,919 | 1,678 | 1,265 | 1,102 | 960.48 |
Income Tax Expense | 418.61 | 396.12 | 276.84 | 243.85 | 204.11 | 181.05 |
Net Income | 1,593 | 1,523 | 1,401 | 1,021 | 897.56 | 779.44 |
Net Income to Common | 1,593 | 1,523 | 1,401 | 1,021 | 897.56 | 779.44 |
Net Income Growth | 10.80% | 8.75% | 37.20% | 13.75% | 15.15% | 64.26% |
Shares Outstanding (Basic) | 145 | 146 | 147 | 147 | 147 | 146 |
Shares Outstanding (Diluted) | 145 | 146 | 147 | 148 | 147 | 147 |
Shares Change | -1.35% | -0.87% | -0.14% | 0.06% | 0.28% | 0.40% |
EPS (Basic) | 11.01 | 10.47 | 9.55 | 6.94 | 6.12 | 5.34 |
EPS (Diluted) | 10.98 | 10.43 | 9.51 | 6.92 | 6.09 | 5.30 |
EPS Growth | 12.37% | 9.67% | 37.43% | 13.63% | 14.91% | 63.58% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 1,609 | 1,650 | 1,662 | 1,302 | 573.63 | 216.31 |
Free Cash Flow Per Share | 11.08 | 11.29 | 11.28 | 8.82 | 3.89 | 1.47 |
Dividend Per Share | 2.460 | 2.400 | 2.120 | 1.920 | 1.760 | 1.680 |
Dividend Growth | 12.33% | 13.21% | 10.42% | 9.09% | 4.76% | 5.66% |
Gross Margin | 61.77% | 61.62% | 59.99% | 57.38% | 56.50% | 57.68% |
Operating Margin | 34.02% | 33.96% | 32.79% | 29.54% | 27.28% | 28.01% |
Profit Margin | 27.79% | 26.95% | 27.22% | 21.79% | 21.25% | 21.78% |
Free Cash Flow Margin | 28.07% | 29.18% | 32.29% | 27.79% | 13.58% | 6.04% |
EBITDA | 2,127 | 2,096 | 1,860 | 1,534 | 1,292 | 1,126 |
EBITDA Margin | 37.09% | 37.07% | 36.15% | 32.73% | 30.60% | 31.47% |
D&A For EBITDA | 176.27 | 175.83 | 173 | 149.42 | 140.1 | 124.06 |
EBIT | 1,950 | 1,920 | 1,687 | 1,384 | 1,152 | 1,002 |
EBIT Margin | 34.02% | 33.96% | 32.79% | 29.54% | 27.28% | 28.01% |
Effective Tax Rate | 20.81% | 20.64% | 16.50% | 19.28% | 18.53% | 18.85% |
Revenue as Reported | 5,733 | 5,653 | 5,146 | 4,685 | 4,223 | 3,578 |